Press release
Second International Conference on Innovations in Pharma R&D | Boston
After the resounding success of its first edition in San Francisco, InnoPharm is set to make an even greater impact with its upcoming global edition-InnoPharm-2026, returning to the East Coast of the United States. This premier international conference will once again bring together leading voices in pharmaceutical sciences, medicinal chemistry, drug discovery, and biotechnology innovation.
InnoPharm-2026 aims to serve as a dynamic global platform for researchers, scientists, industry professionals, and academic leaders to share transformative ideas, explore breakthroughs, and shape the future of healthcare.
W: https://pharm-science.com/
InnoPharm-2026 is now accepting Speakers, Exhibitors, Sponsors, and Delegates. Organizations and individuals seeking to contribute to this high-impact global gathering are invited to apply.
For participation, partnerships, and inquiries, please contact the InnoPharm organizing committee.
Call for Speakers, Exhibitors & Delegates Is Now Open!
Gayatri Srinivas
Conference Manager
Announcing InnoPharm-2026, Where Science Meets Life-Saving Innovation.Join leading researchers, industry experts, and emerging innovators for an exceptional 3day journey into the breakthroughs, collaborations driving the next era of global healthcare
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Second International Conference on Innovations in Pharma R&D | Boston here
News-ID: 4325128 • Views: …
More Releases from Innovations in Pharma R&D
Innovations in Pharma R&D Conference 2025 Unveils Speaker Line-Up for San Franci …
The Innovations in Pharma R&D Conference 2025, scheduled for November 03-05, 2025 in San Francisco, announces its prestigious speaker lineup and a call for abstracts for oral and poster presentations.
Bringing together over 75 international experts from 25+ countries, the conference will serve as a global forum to explore the latest breakthroughs in drug discovery, AI in pharma, clinical research, advanced delivery systems, and regulatory science.
Featured Speakers Include:
Dr. Leslie Z. Benet…
More Releases for InnoPharm
Innovations in Pharma R&D Conference 2025 Unveils Speaker Line-Up for San Franci …
The Innovations in Pharma R&D Conference 2025, scheduled for November 03-05, 2025 in San Francisco, announces its prestigious speaker lineup and a call for abstracts for oral and poster presentations.
Bringing together over 75 international experts from 25+ countries, the conference will serve as a global forum to explore the latest breakthroughs in drug discovery, AI in pharma, clinical research, advanced delivery systems, and regulatory science.
Featured Speakers Include:
Dr. Leslie Z. Benet…
Chronic Brain Damage Market Predicted to See Upsurge Through 2032, Highlights De …
DelveInsight's "Chronic Brain Damage Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Chronic Brain Damage, historical and forecasted epidemiology as well as the Chronic Brain Damage market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Chronic Brain Damage, offering comprehensive insights into the Chronic Brain Damage revenue trends,…
Chronic Brain Damage Market Revenue to Expand Significantly by 2032, States Delv …
The Key Chronic Brain Damage Companies in the market include - Hope Biosciences, Innopharm LLC, SanBio, Inc., Bundang CHA Hospital, Teva Branded Pharmaceutical, Neurocrine Biosciences, Jazz Pharmaceuticals, Avid Radiopharmaceuticals, Rohto Pharmaceutical, Merz Pharmaceuticals, and others.
DelveInsight's "Chronic Brain Damage Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Chronic Brain Damage, historical and forecasted epidemiology as well as the Chronic Brain Damage market trends in the United…
3,3-Dimethylacryclic Acid Methyl Esther Market overview by recent opportunities, …
New York, Global 3,3-Dimethylacryclic Acid Methyl Esther Market report from Global Insight Services is the single authoritative source of intelligence on 3,3-Dimethylacryclic Acid Methyl Esther Market . The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and…
3,3-Dimethylacryclic Acid Methyl Esther Market SWOT analysis, Growth, Share, Siz …
Global 3,3-Dimethylacryclic Acid Methyl Esther report from Global Insight Services is the single authoritative source of intelligence on 3,3-Dimethylacryclic Acid Methyl Esther market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by…
3,3-Dimethylacryclic Acid Methyl Esther Market Research Reports, Industry S-ize, …
New York, Global 3,3-Dimethylacryclic Acid Methyl Esther Market report from Global Insight Services is the single authoritative source of intelligence on 3,3-Dimethylacryclic Acid Methyl Esther Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market…
